Private company

INSPIRE VETERINARY PARTNERS, INC.

INSPIRE VETERINARY PARTNERS, INC. is an American agricultural services company based in Virginia Beach.1

Last updated Oct 20, 2026.

Overview

  • IndustryAgricultural Services1
  • HeadquartersVirginia Beach, Virginia1
  • Incorporated inNV2
  • Business address780 Lynnhaven Pkwy #400, Virginia Beach, Va 234522
  • Filer category, Emerging growth company2
  • Legal formCorporation

Consulting Agreement terminated upon delivery of the shares to Dr. Keiser on March 7, 2024.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-54.4%Operating margin4
-86.0%Net margin4
-0.5%Revenue growth, 20244
-913.2%Return on equity4
7.67×Debt to equity4
-$10.2MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Other costs100¢$16.6M

Out of $16.6M in revenue.4 The company lost money this year.

Financial statements

Revenue54$16.6M in 2024+69% since 2022
0$5.0M$10.0M$15.0M$20.0M2022: $9.8M$9.8M20222023: $16.7M$16.7M2023+70%2024: $16.6M$16.6M2024−0%
Operating income54-$9.0M in 2024+157% since 2022
-$10.0M-$7.5M-$5.0M-$2.5M02022: -$3.5M-$3.5M20222023: -$7.2M-$7.2M2023+104%2024: -$9.0M-$9.0M2024+26%
Net income54-$14.3M in 2024+190% since 2022
-$15.0M-$10.0M-$5.0M02022: -$4.9M-$4.9M20222023: -$14.8M-$14.8M2023+201%2024: -$14.3M-$14.3M2024−4%
Fiscal year2021202220232024
Revenue$9.8M5$16.7M5$16.6M4
Operating expenses$13.4M5$23.9M4$25.6M4
Operating income-$3.5M5-$7.2M4-$9.0M4
Income before tax-$4.9M5-$14.8M4-$14.3M4
Income tax-$30.1K5
Net income-$4.9M5-$14.8M4-$14.3M4

Compare INSPIRE VETERINARY PARTNERS, INC. with another company

Corporate structure

INSPIRE VETERINARY PARTNERS, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of INSPIRE VETERINARY PARTNERS, INC.

  • ARMISTICE CAPITAL, LLC Filed SCHEDULE 13G/A on INSPIRE VETERINARY PARTNERS, INC., latest Nov 14, 2025 (3 filings since May 15, 2025)
  • Ahmed Alomari Filed SC 13G/A on INSPIRE VETERINARY PARTNERS, INC., latest Oct 11, 2024 (2 filings since Jul 19, 2024)
  • Michelle Bartus Filed SC 13G on INSPIRE VETERINARY PARTNERS, INC., latest Nov 14, 2023
  • INSPIRE VETERINARY PARTNERS, INC. Virginia Beach, Virginia

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What INSPIRE VETERINARY PARTNERS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$7.6M4 Dec 31, 2024$8.8M4 Dec 31, 2023−13.1%
Accumulated depreciation$1.2M4 Dec 31, 2024$812.8K4 Dec 31, 2023+51.2%
Property and equipment, net$6.4M4 Dec 31, 2024$7.9M4 Dec 31, 2023−19.7%
Operating-lease assets (leased space)$1.9M4 Dec 31, 2024$1.6M4 Dec 31, 2023+16.3%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$523.7K4 Dec 31, 2024$179.0K4 Dec 31, 2023+192.6%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$8.0M4 Dec 31, 2024$8.1M4 Dec 31, 2023−1.5%
Intangible assets, net (excluding goodwill)$1.6M4 Dec 31, 2024$2.5M4 Dec 31, 2023−35.0%
Accumulated amortization-$1.8M4 Dec 31, 2024-$1.1M4 Dec 31, 2023−58.5%
Finite-lived intangibles, net$1.6M4 Dec 31, 2024$2.5M4 Dec 31, 2023−35.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$516.6K4 Dec 31, 2024$571.5K4 Dec 31, 2023−9.6%

Properties, in its own words

With a decentralized leadership team, our company does not have a physical headquarters, but rather, has a distributed leadership team working from home offices across several states.

Chiefland Animal Hospital (CAH)

The rest of Item 2

The real estate underlying Chiefland Animal Hospital is located at 2630 North Young Boulevard, Chiefland, Florida, and is owned by IVP FL Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $279,500 and was financed by WealthSouth, a division of Farmers National Bank (“WealthSouth”). The material terms of the WealthSouth loan are summarized below.

Pets & Friends Animal Hospital LLC (P&F)

The real estate underlying Pets & Friends Animal Hospital is located at 3625 Baltimore Ave, Pueblo, Colorado, and is owned by IVP CO Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $216,750 and was financed by WealthSouth. The material terms of the WealthSouth loan are summarized below.

Advanced Veterinary Care of Pasco, LLC (AVCP)

The real estate underlying our Advanced Veterinary Care of Pasco facility, located at 12116 Cobble Stone Drive, Hudson, Florida, is leased from Remappa Family Limited Partnership for one year with two additional possible three-year renewals. The initial rent in the first year of the lease is $2,350 per month increasing in annual increments for a total of 0.75% over ten years. The lease consists of 2,442 square feet of commercial space zoned to permit the provision of veterinary services.

Lytle Veterinary Clinic, Inc. (LVC)

The real estate underlying Lytle Veterinary Clinic is located at 63245 Texas State Highway 132, Lytle, Texas, and is owned by IVP TX Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $780,000 and financed by WealthSouth. The material terms of the WealthSouth loan are summarized below.

Southern Kern Veterinary Clinic, Inc. (SKVC)

The real estate underlying Southern Kern Veterinary Clinic is located at 4455 West Rosamond Boulevard, Rosamond, California, and is owned by IVP CA Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $500,000 and financed by WealthSouth. The material terms of the WealthSouth loan are summarized below.

Bartow Animal Hospital

The real estate underlying Bartow Animal Hospital is located at 1515 US Highway 17 South, Bartow, Florida, and is owned by IVP FL Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $350,000 and financed by WealthSouth. The material terms of the WealthSouth loan are summarized below.

The real estate underlying Dietz Family Pet Hospital is located at 7002 Hand Road, Richmond, Texas, and is leased from Clarence and Erna Thielemann for a one-year term, with optional monthly renewals thereafter. The rent is $2,000 per month. The lease consists of 1,880 square feet of commercial space zoned to permit the provision of veterinary services.

The real estate underlying Aberdeen Veterinary Clinic is located at 728 South Philadelphia Boulevard, Aberdeen, Maryland, and is leased from H R Fritz LLC for a five-year term, with three additional optional 5-year renewals. The rent is $4,167 per month, increasing 3% annually. The lease consists of 2,653 square feet of commercial space zoned to permit the provision of veterinary services.

All Breed Pet Care

The real estate underlying the All Breed Pet Care facility is located at 7501 Peachwood Drive, Newburgh, Indiana, and is owned by IVP IN Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $1,200,000 and was financed by WealthSouth. The material terms of the WealthSouth loan are summarized below.

The Pony Express Veterinary Hospital

The real estate underlying The Pony Express Veterinary Hospital is located at 893 Lower Bellbrook Road, Xenia, Ohio and is owned by IVP TX Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $500,000 and was financed by WealthSouth. The material terms of the WealthSouth loan are summarized below.

The real estate underlying The Old 41 Animal Hospital facility is located at 27551 Old 41 Road, Bonita Springs, Florida and 27567 Old 41 Road, Bonita Springs, Florida, and is owned by IVP FL Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $800,000 and was financed by WealthSouth. The material terms of the WealthSouth loan are summarized below.

Valley Veterinary Services

The real estate underlying Valley Veterinary Services facility is located 408 Grace Lane, Rostraver Township, Pennsylvania 15012 (Parcel Nos. 56-12-00-0-148 and 56-12-00-0-144) and is owned by IVP PA Properties, LLC, a 100%-owned subsidiary of the Company. The property was purchased for $590,000 and was financed by WealthSouth. The material terms of the WealthSouth loan are summarized below.

WealthSouth Real Estate Loans

Each WealthSouth loan bears a variable interest rate charged on all sum outstanding equal to the New York Prime Rate plus 0.50%, however, such rate can never be less than 3.57% per annum.

Item 2 of the 10-K filed Mar 31, 2025.3

Leadership

Who has led INSPIRE VETERINARY PARTNERS, INC., and when. Pick a name to see everywhere that person has worked.

Chief operating officer

  1. Charles Stith Keiser2023
2025
Board members and other officers (12)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerRichard Frank named Jan 12, 2024 to Feb 16, 202419
  • DirectorLawrence Alexander named Jan 12, 2024 to Feb 16, 202419
  • DirectorPeter Stith Lau named Jan 27, 2023 to Jan 12, 202420
  • DirectorJames S. Coleman named Jan 27, 2023 to Apr 4, 202321
  • DirectorRichard S. Marten named Jan 27, 2023 to Apr 4, 202321

Timeline

  1. Mar 2, 20268-K Executive or director change22
  2. Jan 21, 20268-K Listing notice or transfer; Other events23
  3. Jan 20, 20268-K Entered a material agreement; Unregistered sale of shares24
  4. Jan 13, 20268-K Bylaws or fiscal year changed25
  5. Jan 12, 20268-K Entered a material agreement; New debt or obligation; Unregistered sale of shares26
  6. Dec 30, 20258-K Entered a material agreement; Unregistered sale of shares27
  7. Dec 17, 20258-K Entered a material agreement28
  8. Dec 11, 20258-K Shareholder vote29
  9. Dec 5, 20258-K Entered a material agreement30
  10. Nov 24, 20258-K Listing notice or transfer31
  11. Nov 17, 20258-K Listing notice or transfer32
  12. Nov 10, 20258-K Entered a material agreement; New debt or obligation; Unregistered sale of shares33

Calendar

When it reported results

  1. Nov 14, 2023Reported quarterly or annual results34

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

236 filings to the SEC since October 2021: 2 annual reports, 8 quarterly reports, 58 major events, 29 insider forms, 6 large holders, 10 private raises, 123 other. The latest 20:

  1. May 7, 202615-12G EDGAR
  2. Mar 31, 2026NT 10-K NOTIFICATION OF LATE FILING EDGAR
  3. Mar 2, 20268-K CURRENT REPORT EDGAR
  4. Jan 30, 2026424B3 PROSPECTUS EDGAR
  5. Jan 29, 2026EFFECT EDGAR
  6. Jan 28, 2026CORRESP EDGAR
  7. Jan 28, 2026S-1/A AMENDMENT NO. 1 TO FORM S-1 EDGAR
  8. Jan 27, 2026UPLOAD EDGAR
  9. Jan 21, 20268-K CURRENT REPORT EDGAR
  10. Jan 20, 20268-K CURRENT REPORT EDGAR
  11. Jan 16, 2026S-1 REGISTRATION STATEMENT EDGAR
  12. Jan 13, 20268-K CURRENT REPORT EDGAR
  13. Jan 12, 20268-K CURRENT REPORT EDGAR
  14. Dec 30, 20258-K CURRENT REPORT EDGAR
  15. Dec 22, 2025DEFA14C INFORMATION STATEMENT EDGAR
  16. Dec 22, 2025DEF 14C INFORMATION STATEMENT EDGAR
  17. Dec 17, 20258-K CURRENT REPORT EDGAR
  18. Dec 12, 2025PRE 14C INFORMATION STATEMENT EDGAR
  19. Dec 11, 20258-K CURRENT REPORT EDGAR
  20. Dec 9, 2025EFFECT EDGAR

The 236 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 4 buys and 2 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 26, 2024Watters TimothyDirectorSale467$0.18$84Form 4
Jul 10, 2024Alomari Ahmed10% ownerSale50,000$9.95$497.5KForm 4
Nov 20, 2023Lawrence AlexanderDirectorBuy1,000$0.56$560Form 4
Nov 17, 2023Keiser Charles StithDirectorBuy1,800$0.51$918Form 4
Nov 16, 2023Thomas-Mackey ErinnDirectorBuy5,600$0.53$3.0KForm 4
Nov 15, 2023Carr KimballSee RemarksBuy5,000$0.55$2.8KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • ARMISTICE CAPITAL, LLCSCHEDULE 13G/A, 3 filings May 15, 2025 to Nov 14, 202535
  • Ahmed AlomariSC 13G/A, 2 filings Jul 19, 2024 to Oct 11, 202436
  • Michelle BartusSC 13G, 1 filing Nov 14, 202337

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2024Kimball Carr55$250.0K$266.5K38
2024Richard Frank57$210.0K$222.3K38
2024Alexandra QuartiDVM51$198.2K$210.0K38
2023President and Chief Executive Officer$233.6K$250.7K38
2023Vice President of Medical Operations$194.3K$204.3K38
2023Chief Financial Officer$191.8K$201.9K38

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jan 14, 2024Filed a private offering of equity Form D: 1 investor so far Form D
  2. Jan 14, 2024Filed a private offering of equity Form D: 1 investor so far Form D
  3. Jan 2, 2024Raised $200,000 in a private offering of equity Form D: 1 investor so far Form D
  4. Nov 8, 2023Raised $400,000 in a private offering of equity Form D: 2 investors so far Form D
  5. Feb 17, 2023Raised $650,000 in a private offering of debt Form D: $10 million offered in all Form D
  6. Jan 24, 2022Raised $4.2 million in a private offering of debt Form D: 3 investors so far Form D
  7. Dec 6, 2021Raised $1 million in a private offering of equity Form D: 1 investor so far Form D
  8. Mar 18, 2021Raised $2.1 million in a private offering of debt Form D: 74 investors so far Form D
  9. Dec 30, 2020Raised $297,000 in a private offering of equity Form D: 26 investors so far Form D
  10. Dec 20, 2020Raised $215 in a private offering of equity Form D: 2 investors so far Form D

SEC filer profile

How INSPIRE VETERINARY PARTNERS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARINSPIRE VETERINARY PARTNERS, INC.1
  • CIK0001939365
  • Employer ID (EIN)85-43592583
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company3
  • Incorporated inNevada3
  • Fiscal year endsDecember 311
  • Industry code (SIC)0700 Agricultural Services1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address780 Lynnhaven Pkwy #400, Virginia Beach, VA 234521
  • Phone(757) 288-30881
  • Shares outstanding3,761,179 as of Nov 12, 20257
  • Public float$6.2M as of Jun 28, 20243
  • AuditorKreit & Chiu CPA LLP, Los Angeles, California PCAOB ID 6651; no auditor attestation of internal control over financial reporting3
  • On EDGAR sinceOct 25, 20221
  • Filings237 in all: 8-K (57), CORRESP (22), UPLOAD (17), S-1/A (16), 3 (15), 4 (14), D (10), EFFECT (8)1
    All 41 form types

    S-1 (8), 10-Q (7), DEF 14C (6), PRE 14C (6), 424B4 (4), DRS/A (4), DRSLTR (4), 424B3 (3), 424B5 (3), DRS (3), 10-K (2), DEF 14A (2), DEFA14C (2), FWP (2), NT 10-K (2), SC 13G (2), SCHEDULE 13G/A (2), 10-Q/A (1), 15-12G (1), 25-NSE (1), 8-A12B (1), 8-K/A (1), ARS (1), CERT (1), DEFA14A (1), DEFR14A (1), PRE 14A (1), RW (1), S-3 (1), S-3/A (1), S-8 (1), SC 13G/A (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2025
    Quarterly report (10-Q) Nov 12, 2025
    Proxy statement (DEF 14A) Oct 24, 2025
    Latest 8-K (8-K) Mar 2, 2026

Securities registered for trading

ClassSymbolExchange
Class A Common Stock, par value $0.0001 per shareIVPNasdaq

From the cover page of the 10-K filed Mar 31, 2025 (Section 12(b) of the Exchange Act).3

Risk factors and legal proceedings

The risks INSPIRE VETERINARY PARTNERS, INC. names in Item 1A of its 10-K filed Mar 31, 2025: 47 risks under these headings, as written.3

  • Risks Related to our Business
  • We have a limited operating history, are not profitable and may never become profitable.
  • If our business plan is not successful, we may not be able to continue operations as a going concern and our shareholders may lose their entire investment in us.
  • If we fail to attract and keep senior management, we may be unable to successfully integrate acquisitions, scale our offerings of veterinary services, and deliver enhanced customer services, which may impact our results of operations and financial results.
  • We may need to raise additional capital to achieve our goals.
  • The Company incurs significant increased expenses and administrative burdens as a public company, which could have an adverse effect on its business, financial condition and results of operations.
  • If we fail to manage our growth effectively, our brand, business and operating results could be harmed.
  • We may seek to grow our business through acquisitions of, or investments in, new or complementary businesses, and facilities, or through strategic alliances, and the failure to manage these acquisitions or strategic alliances, or to integrate them with our existing business, could have a material adverse effect on us.
  • We may seek to raise additional funds in the future through debt financing which may impose operational restrictions on our business and may result in dilution to existing or future holders of our common shares.
  • We may acquire other businesses that may be unsuccessful and could adversely dilute your ownership of our company.
  • We have generated net operating loss carryforwards for U.S. income tax purposes, but our ability to use these net operating losses may be limited by our inability to generate future taxable income.
  • Our management does not have experience as senior management of a public company or ensuring compliance with public company obligations, and fulfilling these obligations will be expensive and time consuming, which may divert management’s attention from the day-to-day operation of its business.
The other 36 risks
  • Failure to maintain effective internal controls over financial reporting could have a material adverse effect on the Company’s business, operating results and stock price.
  • We may incur successor liabilities due to conduct arising prior to the completion of the various acquisitions.
  • Purchasing real estate with hospital acquisitions brings additional complexity and cost.
  • Our estimate of the size of our addressable market may prove to be inaccurate.
  • We may be unable to execute our growth strategies successfully or manage and sustain our growth, and as a result, our business may be adversely affected.
  • We may experience difficulties recruiting and retaining skilled veterinarians due to shortages that could disrupt our business.
  • Negative publicity arising from claims that we do not properly care for animals we handle could adversely affect how we are perceived by the public and reduce our sales and profitability.
  • Our quarterly operating results may fluctuate due to the timing of expenses, veterinary facility acquisitions, veterinary facility closures, and other factors.
  • Our continued success is largely dependent on positive perceptions of our company.
  • Our business may be harmed if our computer network containing employee or other information is compromised, which could adversely affect our results of operations.
  • Labor disputes may have an adverse effect on our operations.
  • We may be subject to personal injury, workers’ compensation, discrimination, harassment, wrongful termination, wage and hour, and other claims in the ordinary course of business.
  • A decline in consumer spending or a change in consumer preferences or demographics could reduce our sales or profitability and adversely affect our business.
  • Our reputation and business may be harmed if our or our vendors’ computer network security or any of the databases containing customer, employee, or other personal information maintained by us or our third-party providers is compromised, which could materially adversely affect our results of operations.
  • The animal health industry is highly competitive.
  • We may be unable to adequately protect our intellectual property rights.
  • We may be subject to litigation.
  • Natural disasters and other events beyond our control could harm our business.
  • Risks Related to Government Regulation
  • Various government regulations could limit or delay our ability to develop and commercialize our services or otherwise negatively impact our business.
  • Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, investments and results of operations.
  • Failure to comply with governmental regulations or the expansion of existing or the enactment of new laws or regulations applicable to our veterinary services could adversely affect our business and our financial condition or lead to fines, litigation, or our inability to offer veterinary products or services in certain states.
  • We may fail to comply with various state or federal regulations covering the dispensing of prescription pet medications, including controlled substances, through our veterinary services businesses, which may subject us to reprimands, sanctions, probations, fines, or suspensions.
  • We are subject to environmental, health, and safety laws and regulations that could result in costs to us.
  • Risks Related to our Common Shares and Securities
  • We have received a listing deficiency notice from Nasdaq regarding our Class A Common Stock.
  • If our Class A Common Stock becomes subject to the penny stock rules, it may be more difficult to sell our Class A Common Stock.
  • It is not possible to predict the actual number of shares we will sell under the Purchase Agreement, or the actual gross proceeds resulting from those sales. We may not have access to the full amount available under the Purchase Agreement with Tumim.
  • Investors who buy shares at different times will likely pay different prices.
  • If securities or industry analysts do not publish research or reports about our company, or if they issue adverse or misleading opinions regarding us or our stock, our stock price and trading volume could decline.
  • We do not intend to pay cash dividends for the foreseeable future.
  • Our shares will be subordinate to all of our debts and liabilities, which increases the risk that you could lose your entire investment.
  • Our board of directors may designate and issue shares of new classes of stock, including the issuance of up to 16,108,500 additional shares of Class B common stock, that could be superior to or adversely affect you as a holder of our Class A common stock. Although a majority of our board of directors are independent, our non-independent directors, officers, and their affiliates control approximately 98.0% of the voting power of our outstanding common stock.
  • The trading price of our Class A common stock is volatile, which could result in substantial losses to investors.
  • The sale or availability for sale of substantial amounts of our Class A common stock could adversely affect their market price.
  • We are an “emerging growth company” and a “smaller reporting company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies and a smaller reporting companies will make our Class A Common Stock less attractive to investors.
  • We may be deemed a “controlled company” within the meaning of the rules of Nasdaq and, as a result, may qualify for, but do not intend to rely on, exemptions from certain corporate governance requirements.
  • Sales of a significant number of shares of our Class A Common Stock in the public markets, or the perception that such sales could occur, could depress the market price of our Class A Common Stock.

Legal proceedings

We are not aware of any pending legal proceedings to which we are a party, or to which any director, officer or affiliate of our Company, or any owner of record or beneficially of more than 5% of any class of our voting securities, is a party adverse to us or has a material interest adverse to us.

The opening of Item 3, Legal Proceedings.3

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38